Edwards focuses on peripheral stent development
This article was originally published in Clinica
Edwards Lifesciences has formed two deals aimed at strengthening its position in treatments for peripheral vascular disease. Under the first deal, it has gained non-coronary stent technologies from private company Orbus Medical Technologies through an exclusive licensing agreement. The second is a related product development agreement with private company Syntheon.